heroin and Respiration-Disorders

heroin has been researched along with Respiration-Disorders* in 4 studies

Other Studies

4 other study(ies) available for heroin and Respiration-Disorders

ArticleYear
Recurrent opioid toxicity after pre-hospital care of presumed heroin overdose patients.
    Acta anaesthesiologica Scandinavica, 2006, Volume: 50, Issue:10

    In patients with presumed heroin overdose, the recommended time of observation after reversing heroin toxicity with naloxone varies widely. The aims of this study were to examine the incidence of recurrent opioid toxicity and the time interval in which it occurs after pre-hospital treatment in presumed heroin overdose patients.. We undertook a retrospective study in Helsinki (population, 560,000). Records were reviewed from 1 January 1995 to 31 December 2000. Patients included were treated by the emergency medical service (EMS) for a presumed heroin overdose. Patients with known polydrug/alcohol use or the use of opioids other than heroin were excluded. The EMS records were compared with the cardiac arrest database and the medical examiners' records.. One hundred and forty-five patients were included. The median dose of pre-hospital administered naloxone was 0.4 mg. After pre-hospital care, 84 patients refused further care and were not transported to an emergency department (ED). Seventy-one received pre-hospital naloxone, and no life-threatening events were recorded during a 12-h follow-up period in these patients. After pre-hospital care, 61 patients were transported to an ED. Twelve patients received naloxone in the ED for respiratory depression. All had signs of heroin use-related adverse events within 1 h after receiving pre-hospital naloxone.. Allowing presumed heroin overdose patients to sign out after pre-hospital care with naloxone is safe. If transported to an ED, a 1-h observation period after naloxone administration seems to be adequate for recurrent heroin toxicity.

    Topics: Administration, Inhalation; Adult; Analgesics, Opioid; Drug Overdose; Emergency Medical Services; Female; Finland; Heroin; Humans; Injections; Male; Medical Records; Recurrence; Reproducibility of Results; Respiration Disorders; Retrospective Studies

2006
Non-fatal heroin overdoses.
    The Medical journal of Australia, 1994, Nov-07, Volume: 161, Issue:9

    Topics: Adult; Cause of Death; Drug Overdose; Female; Heroin; Heroin Dependence; Humans; Male; Respiration Disorders; Syncope

1994
Heroin and medical reasoning: the power of analogy.
    New York state journal of medicine, 1986, Volume: 86, Issue:3

    Topics: Heroin; History, 19th Century; History, 20th Century; Humans; Respiration Disorders; United States

1986
Accelerated development of pulmonary complications due to illicit intravenous use of pentazocine and tripelennamine.
    The American journal of medicine, 1984, Volume: 76, Issue:4

    To gain information concerning the natural history and prevalence of pulmonary gas exchange abnormalities resulting from intravenous drug abuse, 45 intravenous drug users were studied. Twenty subjects used a mixture of the synthetic opiate pentazocine and the antihistamine tripelennamine, which, under the street name T's and B's, has become very popular in some urban areas as an available substitute for heroin. Compared with the 19 heroin addicts studied, the pentazocine and tripelennamine users had a significantly shorter mean duration of intravenous drug abuse (2.7 +/- 0.4 years versus 7.6 +/- 0.9 years, p less than 0.01), a greater frequency of respiratory symptoms (75 percent versus 36 percent, p less than 0.05), a significant reduction in the mean diffusing capacity of the lung for carbon monoxide (58.4 +/- 3.3 percent predicted versus 75.5 +/- 5.6 percent predicted, p less than 0.01), and abnormal responses to submaximal steady-state exercise testing. The intravenous use of pentazocine and tripelennamine and probably most other drug preparations intended for nonparenteral use represents a particularly noxious form of drug abuse that may lead to early respiratory complications in a large proportion of users.

    Topics: Adult; Exercise Test; Female; Heroin; Humans; Lung; Male; Pentazocine; Respiration Disorders; Substance-Related Disorders; Time Factors; Tripelennamine

1984